Abstract 2458: Prediction of atezolizumab benefit in NSCLC by computational pathology: Retrospective validation in a phase III trial
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: Genentech, Lunit (South Korea)
Language: English
Topic: AI in cancer detection
Subfield: Artificial Intelligence
Field: Computer Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W4409689741